N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide

C163H219BrF8N14O7 — CID 160700469

IUPACN-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide
SMILESO=C(N[C@H]1CCN(CCCc2ccccc2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2ccc(Br)cc2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2cccc(C(F)(F)F)c2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2cccc(F)c2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2ccccc2C(F)(F)F)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2ccccc2F)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(Cc2ccccc2)C1)C12CC3CC(CC(C3)C1)C2
InChIInChI=1S/2C24H31F3N2O.C24H34N2O.C23H31BrN2O.2C23H31FN2O.C22H30N2O/c25-24(26,27)20-3-1-2-16(11-20)4-6-29-7-5-21(15-29)28-22(30)23-12-17-8-18(13-23)10-19(9-17)14-23;25-24(26,27)21-4-2-1-3-19(21)5-7-29-8-6-20(15-29)28-22(30)23-12-16-9-17(13-23)11-18(10-16)14-23;27-23(24-14-19-11-20(15-24)13-21(12-19)16-24)25-22-8-10-26(17-22)9-4-7-18-5-2-1-3-6-18;24-20-3-1-16(2-4-20)5-7-26-8-6-21(15-26)25-22(27)23-12-17-9-18(13-23)11-19(10-17)14-23;24-20-3-1-2-16(11-20)4-6-26-7-5-21(15-26)25-22(27)23-12-17-8-18(13-23)10-19(9-17)14-23;24-21-4-2-1-3-19(21)5-7-26-8-6-20(15-26)25-22(27)23-12-16-9-17(13-23)11-18(10-16)14-23;25-21(22-11-17-8-18(12-22)10-19(9-17)13-22)23-20-6-7-24(15-20)14-16-4-2-1-3-5-16/h1-3,11,17-19,21H,4-10,12-15H2,(H,28,30);1-4,16-18,20H,5-15H2,(H,28,30);1-3,5-6,19-22H,4,7-17H2,(H,25,27);1-4,17-19,21H,5-15H2,(H,25,27);1-3,11,17-19,21H,4-10,12-15H2,(H,25,27);1-4,16-18,20H,5-15H2,(H,25,27);1-5,17-20H,6-15H2,(H,23,25)/t17?,18?,19?,21-,23?;16?,17?,18?,20-,23?;19?,20?,21?,22-,24?;2*17?,18?,19?,21-,23?;16?,17?,18?,20-,23?;17?,18?,19?,20-,22?/m0000000/s1
InChIKeyRQNZKPCIVXCJIQ-JDCIJNEOSA-N
MW2718.52 g/mol
LogP28.88
Rot. Bonds35

About N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide

N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide (PubChem CID 160700469) has the molecular formula C163H219BrF8N14O7 and a molecular weight of 2718.52 g/mol. Its IUPAC name is N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide.

Molecular Properties

Compound NameN-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide
PubChem CID160700469
Molecular FormulaC163H219BrF8N14O7
Molecular Weight2718.52 g/mol
Exact Mass2715.63
IUPAC NameN-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide
SMILESO=C(N[C@H]1CCN(CCCc2ccccc2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2ccc(Br)cc2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2cccc(C(F)(F)F)c2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2cccc(F)c2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2ccccc2C(F)(F)F)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2ccccc2F)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(Cc2ccccc2)C1)C12CC3CC(CC(C3)C1)C2
InChIInChI=1S/2C24H31F3N2O.C24H34N2O.C23H31BrN2O.2C23H31FN2O.C22H30N2O/c25-24(26,27)20-3-1-2-16(11-20)4-6-29-7-5-21(15-29)28-22(30)23-12-17-8-18(13-23)10-19(9-17)14-23;25-24(26,27)21-4-2-1-3-19(21)5-7-29-8-6-20(15-29)28-22(30)23-12-16-9-17(13-23)11-18(10-16)14-23;27-23(24-14-19-11-20(15-24)13-21(12-19)16-24)25-22-8-10-26(17-22)9-4-7-18-5-2-1-3-6-18;24-20-3-1-16(2-4-20)5-7-26-8-6-21(15-26)25-22(27)23-12-17-9-18(13-23)11-19(10-17)14-23;24-20-3-1-2-16(11-20)4-6-26-7-5-21(15-26)25-22(27)23-12-17-8-18(13-23)10-19(9-17)14-23;24-21-4-2-1-3-19(21)5-7-26-8-6-20(15-26)25-22(27)23-12-16-9-17(13-23)11-18(10-16)14-23;25-21(22-11-17-8-18(12-22)10-19(9-17)13-22)23-20-6-7-24(15-20)14-16-4-2-1-3-5-16/h1-3,11,17-19,21H,4-10,12-15H2,(H,28,30);1-4,16-18,20H,5-15H2,(H,28,30);1-3,5-6,19-22H,4,7-17H2,(H,25,27);1-4,17-19,21H,5-15H2,(H,25,27);1-3,11,17-19,21H,4-10,12-15H2,(H,25,27);1-4,16-18,20H,5-15H2,(H,25,27);1-5,17-20H,6-15H2,(H,23,25)/t17?,18?,19?,21-,23?;16?,17?,18?,20-,23?;19?,20?,21?,22-,24?;2*17?,18?,19?,21-,23?;16?,17?,18?,20-,23?;17?,18?,19?,20-,22?/m0000000/s1
InChIKeyRQNZKPCIVXCJIQ-JDCIJNEOSA-N
XLogP28.88
TPSA226.38 Ų
H-Bond Donors7
H-Bond Acceptors14
Rotatable Bonds35
Heavy Atoms193
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002718.52
LogP ≤ 528.88
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1014

Analyze N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;hydrate;hydrochloride
CID 70172047
N-[1-[2-[4-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide
CID 22888129
N-[(3R)-1-benzylpyrrolidin-3-yl]-2-(3-fluorophenyl)acetamide
CID 39959483
N-[(2R)-1-[[(3R)-1-benzylpyrrolidin-3-yl]amino]-3-methyl-1-oxobutan-2-yl]adamantane-1-carboxamide
CID 39910717
[(3R)-1-(3-phenylpropyl)pyrrolidin-3-yl]carbamic acid
CID 154457780
2-phenyl-N-[1-[[3-(trifluoromethyl)phenyl]methyl]piperidin-4-yl]acetamide
CID 10948807
1-(3-phenylpropyl)-4-[2-[2-(trifluoromethyl)phenyl]ethyl]piperazine
CID 66985068
N-(1-benzylpiperidin-4-yl)-2-[2-(trifluoromethyl)phenyl]acetamide
CID 11793930
N-(1-benzylpyrrolidin-3-yl)-2-bromo-5-fluorobenzamide
CID 18156414
1-benzyl-N-[[2-(trifluoromethyl)phenyl]methyl]pyrrolidin-3-amine
CID 55378502
1-[(3-fluorophenyl)methyl]-4-(3-phenylpropyl)piperazine;oxalic acid
CID 90483959
5-methyl-N-[1-(2-phenylethyl)pyrrolidin-3-yl]-1-azatricyclo[3.3.1.13,7]decane-3-carboxamide
CID 70176418

Frequently Asked Questions

What is the IUPAC name of N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide?
The IUPAC name of N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide (CID 160700469) is N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide.
What is the SMILES notation for N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide?
The canonical SMILES for N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide is O=C(N[C@H]1CCN(CCCc2ccccc2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2ccc(Br)cc2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2cccc(C(F)(F)F)c2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2cccc(F)c2)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2ccccc2C(F)(F)F)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(CCc2ccccc2F)C1)C12CC3CC(CC(C3)C1)C2.O=C(N[C@H]1CCN(Cc2ccccc2)C1)C12CC3CC(CC(C3)C1)C2.
What is the InChIKey of N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide?
The InChIKey is RQNZKPCIVXCJIQ-JDCIJNEOSA-N. The full InChI is InChI=1S/2C24H31F3N2O.C24H34N2O.C23H31BrN2O.2C23H31FN2O.C22H30N2O/c25-24(26,27)20-3-1-2-16(11-20)4-6-29-7-5-21(15-29)28-22(30)23-12-17-8-18(13-23)10-19(9-17)14-23;25-24(26,27)21-4-2-1-3-19(21)5-7-29-8-6-20(15-29)28-22(30)23-12-16-9-17(13-23)11-18(10-16)14-23;27-23(24-14-19-11-20(15-24)13-21(12-19)16-24)25-22-8-10-26(17-22)9-4-7-18-5-2-1-3-6-18;24-20-3-1-16(2-4-20)5-7-26-8-6-21(15-26)25-22(27)23-12-17-9-18(13-23)11-19(10-17)14-23;24-20-3-1-2-16(11-20)4-6-26-7-5-21(15-26)25-22(27)23-12-17-8-18(13-23)10-19(9-17)14-23;24-21-4-2-1-3-19(21)5-7-26-8-6-20(15-26)25-22(27)23-12-16-9-17(13-23)11-18(10-16)14-23;25-21(22-11-17-8-18(12-22)10-19(9-17)13-22)23-20-6-7-24(15-20)14-16-4-2-1-3-5-16/h1-3,11,17-19,21H,4-10,12-15H2,(H,28,30);1-4,16-18,20H,5-15H2,(H,28,30);1-3,5-6,19-22H,4,7-17H2,(H,25,27);1-4,17-19,21H,5-15H2,(H,25,27);1-3,11,17-19,21H,4-10,12-15H2,(H,25,27);1-4,16-18,20H,5-15H2,(H,25,27);1-5,17-20H,6-15H2,(H,23,25)/t17?,18?,19?,21-,23?;16?,17?,18?,20-,23?;19?,20?,21?,22-,24?;2*17?,18?,19?,21-,23?;16?,17?,18?,20-,23?;17?,18?,19?,20-,22?/m0000000/s1.
What are the key properties of N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide?
N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide has a molecular weight of 2718.52 g/mol, XLogP of 28.88, 35 rotatable bonds, 7 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S)-1-benzylpyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(4-bromophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(2-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-(3-fluorophenyl)ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-(3-phenylpropyl)pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[2-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide;N-[(3S)-1-[2-[3-(trifluoromethyl)phenyl]ethyl]pyrrolidin-3-yl]adamantane-1-carboxamide is sourced from PubChem (CID 160700469), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).